Last updated: 18 June 2019 at 5:17am EST

Joseph Lambing Net Worth




The estimated Net Worth of Joseph Lambing is at least $22.3 Milión dollars as of 26 February 2018. Joseph Lambing owns over 2,300 units of MyoKardia stock worth over $21,039,431 and over the last 9 years Joseph sold MYOK stock worth over $1,263,000.

Joseph Lambing MYOK stock SEC Form 4 insiders trading

Joseph has made over 5 trades of the MyoKardia stock since 2017, according to the Form 4 filled with the SEC. Most recently Joseph sold 2,300 units of MYOK stock worth $138,000 on 26 February 2018.

The largest trade Joseph's ever made was selling 15,000 units of MyoKardia stock on 7 August 2017 worth over $450,000. On average, Joseph trades about 1,538 units every 10 days since 2016. As of 26 February 2018 Joseph still owns at least 93,546 units of MyoKardia stock.

You can see the complete history of Joseph Lambing stock trades at the bottom of the page.



What's Joseph Lambing's mailing address?

Joseph's mailing address filed with the SEC is 333 Allerton Ave, South San Francisco, CA 94080, USA.

Insiders trading at MyoKardia

Over the last 9 years, insiders at MyoKardia have traded over $313,807,381 worth of MyoKardia stock and bought 2,317,816 units worth $42,556,877 . The most active insiders traders include Sanofi, Kevin P Starr a Rock Ventures Ii, L.P.Third.... On average, MyoKardia executives and independent directors trade stock every 16 days with the average trade being worth of $21,462,936. The most recent stock trade was executed by Anastasios Gianakakos on 2 July 2020, trading 5,000 units of MYOK stock currently worth $469,900.



What does MyoKardia do?

MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA.



What does MyoKardia's logo look like?

MyoKardia, Inc. logo

Complete history of Joseph Lambing stock trades at MyoKardia

Dátum
#
Spoločnosť
Človek
Trans.
Transakcia
Počet akcií Cena za akciu Celková cena Počet akcií po Zdroj
26 Feb 2018 Joseph Lambing
See Remarks
Predaj 2,300 $60.00 $138,000
26 Feb 2018
93,546
12 Jan 2018 Joseph Lambing
See Remarks
Predaj 5,000 $50.00 $250,000
12 Jan 2018
95,846
22 Aug 2017 Joseph Lambing
See Remarks
Predaj 5,000 $45.00 $225,000
22 Aug 2017
99,718
15 Aug 2017 Joseph Lambing
See Remarks
Predaj 5,000 $40.00 $200,000
15 Aug 2017
104,718
7 Aug 2017 Joseph Lambing
See Remarks
Predaj 15,000 $30.00 $450,000
7 Aug 2017
109,718


MyoKardia executives and stock owners

MyoKardia executives and other stock owners filed with the SEC include: